These findings suggest that the IL-11-overexpressing subclone may act altruistically in a tumor with a fast-growing subclone free-riding on its ‘public goods’ contribution, thus incurring a fitness cost while supporting overall tumor growth. Here, IL11 is linked to neoplasm.